News Focus
News Focus
icon url

danielboog2

09/19/25 7:45 PM

#789028 RE: WideEyed #789027

Thank you WideEyed. Absolutely astounding the compatible combinations with DC Vax. My only response....your list of apparent uses are only a limited usage. My opinion, every known treatment is significantly enhanced with DC Vax where the immune system is involved.
Thanks again.
icon url

skitahoe

09/19/25 7:56 PM

#789030 RE: WideEyed #789027

Please help me to understand, once DCVAX-L is approved, what prevents any other approved therapeutic to be used with it off label. 
I understand that some trials will be run with certain therapeutics, and they will pay and possible have the inside track, but how is a competitors drug not permitted to be used off label?
Gary 
icon url

RobotDroid

09/19/25 8:02 PM

#789032 RE: WideEyed #789027

I long way to describe Hopium, nothing more.
icon url

RRP60

09/19/25 8:03 PM

#789033 RE: WideEyed #789027

Man, we frequently need your vision and optimism here. Iam so tired of reading these noninvested skeptics nonstop nonsense. Let the king bless our drug and these guys will be toast with any of your scenarios. I may call in when nwbo announce buyback to watch shorts getting fried in real time. Cant miss that action. 
Bullish
Bullish
icon url

AllSheWrote

09/19/25 8:39 PM

#789034 RE: WideEyed #789027

It hasn't been approved for ANYTHING. They submitted to the MHRA almost two years ago! Do you think that's normal? Do you think there might be a major problem here? And if by some miracle they do get approval, it would be for the UK - because they didn't even bother to submit to the FDA. You might want to temper your fantasies.
icon url

Investor082

09/19/25 9:04 PM

#789037 RE: WideEyed #789027

Make sure LP doesn’t ask shareholders to vote for another 500-750M share increase. That wouldn’t be a good outcome and your theory will be tossed! ;)
icon url

jesster64

09/19/25 11:09 PM

#789051 RE: WideEyed #789027

Serious question. Would trials of combinations with dc-vax first have to be held before any combo can be prescribed after dc-vax approval? While the franchise model makes sense, you can't just prescribe a combo with dc-vax. Combo trials have to be held to check for any side effects or just for effectiveness. So the thought that approval brings on immediate revenue with franchising wouldnt make sense because there is no data for the majority of combos. Am I wrong?
icon url

ROS-CH

09/20/25 4:01 AM

#789062 RE: WideEyed #789027

Finally, I start to understand :

Keytruda expires in Dec. 2028 and you label that "right around the corner".

Many posters claimed DCVax-approval is "around the corner" or "imminent".

Taking the timing-guidance from your post does that mean DCVax will be approved
somewhen in 2027 or 2028 ?

(Asking for my wife)